Title: Rechargeable drug delivery method

Do you think this is a good invention? Vote now:

Votes so far: For:(0) Against:(0)
Claims: What is claimed is:

1. A method of delivering a selected drug to a preselected area of a living body comprising the steps of:

providing a solid receptor chemical compound having an affinity for said selected drug, reducing the solid compound to particles selecting a hydrophillic material permable to the drug when in solution, embedding the particles of said receptor chemical compound in said hydrophillic material,

attaching said drug to said receptor chemical compound by a reversible bond, and

reversing said bond to permit release the drug from the receptor chemical compound resulting in said drug going into solution within the permeable hydrophillic material,

permitting a timed reversal of said bond release to continue until substantially all the solid phase of said material substantially becomes a solution whereby the drug solution may diffuse to the surface of the permeable hydrophillic material and is released to said preselected area of the living body at a preselected rate.

2. The method of claim 1 and further comprising:

replenishing the quantity of said drug present in the drug depleted receptor chemical compound by immersion of the hydrophillic material in a solution containing said drug.

3. The method of recharging a drug delivery eye contact lens having an outer peripheral segment of a hydrated hydrophillic matrix containing a drug in a reversible bond, said lens further having an unmedicated transparent central optical segment comprising the steps of: removing the lens from the cornea of the eye,

immersing the lens in a solution containing a quantity of the drug,

permitting the immersed lens to remain in the drug solution until it has absorbed a preselected quantity of the drug within the outer peripheral segment of the lens to recharge the lens,

applying the recharged lens to a cornea, and thereby releasing quantities of the drug from the lens to the epithelium of the cornea at a preselected slow delivery rate over an extended period of time.

4. The method of claim 3 and further comprising:

immersing said lens in water to thereby pre-extract excess drug therefrom, and

determining the desired effective therapeutic level of drug remaining in the lens by assay of removed drug present in the water to determine the residual drug remaining in the lens.

Other info:

Inventors: Neefe, Charles W. (Big Spring, TX, US)

Application Number: 579796
Filing Date: 1975-05-22
Publication_date: 1976-05-18
Assignee:
Primary Class(es): 424/429 351/160R, 604/294, 604/500, 604/521
Other Classes:
US Patent Ref:

2241415	May, 1941	Moulton	351/160.
3488111	Jan, 1970	Isen	351/160.
3618604	Nov, 1971	Ness	128/260.
3710796	Jan, 1973	Neefe	128/260.
3786812	Jan, 1974	Neefe	128/260.
3870791	Mar, 1975	Haddad	424/22.

Other Refs:
Primary Examiner: Medbery, Aldrich F.
Assistant Examiner:
Attorney: